BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2016
View Archived Issues
Ember Therapeutics acquires ICX-RHY from Intercytex
Read More
68Ga-DOTA-E[c(RGDfK)]2 as potential tracer for tumor angiogenesis imaging
Read More
Fujifilm demonstrates potential of Cellnest in bone regeneration
Read More
Lilly reports FFA1 receptor agonists for type 2 diabetes
Read More
FDA grants orphan drug designation to SPK-TPP1 for the treatment of CLN2 disease
Read More
Merck & Co. patents DGAT-2 inhibitors
Read More
CTxT Pty discloses PRMT5 inhibitors
Read More
FLT3 and JAK inhibitors described in Pierre Fabre patent
Read More
Toray Industries introduces IL-23 receptor ligands
Read More
CHDI Foundation reports PET probes
Read More
Pfizer divulges JAK inhibitors
Read More
Anti-Notch 3 ADC from Pfizer shows signs of efficacy in phase I study
Read More
Ajinomoto and Mochida to jointly develop AJG-533 in Japan
Read More
New role of RUNX3 as a prognostic biomarker for diffuse large B-cell lymphoma
Read More
Ono seeks Japanese approval of Opdivo for relapsed or refractory Hodgkin's lymphoma
Read More
Cymbalta approved in Japan for chronic lower back pain
Read More
New animal model to study the role of Maspin in prostatic intraepithelial hyperplasia
Read More
The Garvan Institute of Medical Research receives funding from NHMRC
Read More
Sumitomo Dainippon discovers novel orally available human neutrophil elastase inhibitors
Read More
Eisai announces discontinuation of sales and voluntary recall of egg white lysozyme preparation
Read More
Promising topline data from phase III study of romosozumab in men with osteoporosis
Read More
Omnis Pharma and Magnis Therapeutics merge to form Vyriad
Read More
Symphogen initiates phase I/II trial of Sym-015 in advanced solid tumor malignancies
Read More
miR-122-5p shows promise as a biomarker for liver injury
Read More
Affymetrix continues to recommend Thermo Fisher merger following Origin proposal
Read More
Proemend approved in Japan for CINV in pediatic patients
Read More
ProMIS Neurosciences identifies third therapeutic target for Alzheimer's disease
Read More